| Primary |
| Rheumatoid Arthritis |
67.1% |
| Prophylaxis |
3.5% |
| Product Used For Unknown Indication |
3.2% |
| Analgesia |
2.6% |
| Gastritis Prophylaxis |
2.6% |
| Gastritis |
2.3% |
| Hypertension |
2.3% |
| Prophylaxis Against Gastrointestinal Ulcer |
2.3% |
| Hyperlipidaemia |
1.6% |
| Interstitial Lung Disease |
1.6% |
| Osteoporosis |
1.6% |
| Pain |
1.6% |
| Gastric Mucosal Lesion |
1.3% |
| Gastrooesophageal Reflux Disease |
1.3% |
| Infection Prophylaxis |
1.0% |
| Reflux Oesophagitis |
1.0% |
| Type 1 Diabetes Mellitus |
1.0% |
| Xeroderma |
1.0% |
| Alopecia Areata |
0.6% |
| Constipation |
0.6% |
|
| Pneumonia |
10.4% |
| Gastric Cancer |
8.3% |
| Pancytopenia |
8.3% |
| Appendicitis |
6.3% |
| Interstitial Lung Disease |
6.3% |
| Pyrexia |
6.3% |
| Bronchopulmonary Aspergillosis |
4.2% |
| Deafness |
4.2% |
| Fracture |
4.2% |
| Haemorrhage Subcutaneous |
4.2% |
| Large Intestine Carcinoma |
4.2% |
| Lupus Nephritis |
4.2% |
| Lymphoproliferative Disorder |
4.2% |
| Mitral Valve Incompetence |
4.2% |
| Pelvic Abscess |
4.2% |
| Pneumonia Chlamydial |
4.2% |
| Pneumothorax |
4.2% |
| Thrombocytopenia |
4.2% |
| Accident |
2.1% |
| Antineutrophil Cytoplasmic Antibody Positive |
2.1% |
|
| Secondary |
| Rheumatoid Arthritis |
67.8% |
| Prophylaxis |
7.0% |
| Osteoporosis |
3.5% |
| Hypertension |
3.1% |
| Drug Use For Unknown Indication |
2.6% |
| Gastritis |
2.4% |
| Antibiotic Prophylaxis |
2.3% |
| Product Used For Unknown Indication |
2.1% |
| Diabetes Mellitus |
1.2% |
| Insomnia |
1.1% |
| Constipation |
1.1% |
| Prophylaxis Against Gastrointestinal Ulcer |
1.0% |
| Hyperlipidaemia |
0.8% |
| Gastric Ulcer |
0.8% |
| Gastritis Prophylaxis |
0.6% |
| Gastrointestinal Disorder Therapy |
0.6% |
| Osteoporosis Prophylaxis |
0.6% |
| Pain |
0.5% |
| Psoriatic Arthropathy |
0.5% |
| Reflux Oesophagitis |
0.5% |
|
| Pneumocystis Jiroveci Pneumonia |
22.9% |
| Interstitial Lung Disease |
12.3% |
| Pneumonia |
10.1% |
| Pulmonary Tuberculosis |
6.1% |
| Rheumatoid Arthritis |
4.6% |
| Pyrexia |
4.3% |
| Stomatitis |
4.2% |
| Lymphoma |
4.1% |
| White Blood Cell Count Decreased |
3.8% |
| Sepsis |
3.5% |
| Vomiting |
3.3% |
| Staphylococcal Infection |
3.0% |
| Tuberculous Pleurisy |
2.9% |
| Tuberculosis |
2.8% |
| Urinary Tract Infection |
2.7% |
| Bone Neoplasm |
2.0% |
| Disseminated Tuberculosis |
2.0% |
| Upper Respiratory Tract Inflammation |
2.0% |
| Pneumonia Cryptococcal |
1.9% |
| B-cell Lymphoma |
1.8% |
|
| Concomitant |
| Rheumatoid Arthritis |
68.1% |
| Prophylaxis |
7.5% |
| Osteoporosis |
3.8% |
| Hypertension |
3.2% |
| Antibiotic Prophylaxis |
1.9% |
| Drug Use For Unknown Indication |
1.9% |
| Gastritis |
1.7% |
| Diabetes Mellitus |
1.4% |
| Product Used For Unknown Indication |
1.4% |
| Insomnia |
1.2% |
| Constipation |
1.2% |
| Juvenile Arthritis |
1.0% |
| Gastric Ulcer |
1.0% |
| Behcet's Syndrome |
0.9% |
| Prophylaxis Against Gastrointestinal Ulcer |
0.9% |
| Osteoporosis Prophylaxis |
0.6% |
| Pain |
0.6% |
| Musculoskeletal Pain |
0.5% |
| Gastrointestinal Disorder Therapy |
0.5% |
| Reflux Oesophagitis |
0.5% |
|
| Pneumocystis Jiroveci Pneumonia |
10.9% |
| Pulmonary Tuberculosis |
7.7% |
| Pyrexia |
7.7% |
| Tuberculous Pleurisy |
6.5% |
| Rash |
6.2% |
| Vomiting |
5.4% |
| White Blood Cell Count Decreased |
5.4% |
| Breast Cancer |
5.1% |
| Pneumonia |
5.1% |
| Rheumatoid Arthritis |
5.1% |
| Urinary Tract Infection |
4.8% |
| Gastric Cancer |
4.5% |
| Interstitial Lung Disease |
4.5% |
| Sepsis |
4.2% |
| Skin Ulcer |
3.4% |
| Tuberculosis |
3.4% |
| Hypoglycaemia |
2.7% |
| Retinal Haemorrhage |
2.7% |
| Cerebral Haemorrhage |
2.4% |
| Death |
2.4% |
|
| Interacting |
| Rheumatoid Arthritis |
66.7% |
| Prophylaxis |
33.3% |
|
| White Blood Cell Count Decreased |
100.0% |
|
